Protagonist Therapeutics ($PTGX) Insider Trading & Smart Money Activity
Protagonist Therapeutics, Inc. ($PTGX) has 3 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($8.31M), net -$8.31M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$8.31M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
PTGX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 1 · $8.31M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All PTGX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Ali AsifChief Financial Officer | Sell (Open-market sale) 10b5-1 | 58.63K sh | $8.31M | 0.0% | — | |||||
| Insider | William Waddill | Sell (Option exercise) | 9K sh | +3.0% | +13.8% | — | |||||
| Insider | William Waddill | Buy (Option exercise) | 9K sh | $148.86K | +3.0% | +13.8% | — | ||||
| 13F | Farallon Capital Management | Added | +204.90K sh | $696.98M | -2.9% | +10.1% | — | ||||
| 13F | Farallon Capital Management | Added | +204.90K sh | $778.25M | -2.9% | +10.1% | Read |
1W / 1M / 6M = how PTGX moved from the trade or filing date.
Insider trading in PTGX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Ali Asif | Chief Financial Officer | 1 | -$8.31M | Sep 30, 2026 | |
| William Waddill | 2 | — | Jun 23, 2026 |
Institutions moving PTGX (13F)
Frequently asked questions
Are PTGX insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $8.31M, a net -$8.31M.
What is the latest insider trade in PTGX?
Ali Asif, Chief Financial Officer filed a sell (open-market sale) of 58.63K sh worth $8.31M on Sep 30, 2026.
Which institutions changed their PTGX positions?
Recent 13F filers moving the stock include Farallon Capital Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.